These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 3929780

  • 1. Irreversible platelet aggregation does not depend on lipoxygenase metabolites.
    Rao GH, Radha E, White JG.
    Biochem Biophys Res Commun; 1985 Aug 30; 131(1):50-7. PubMed ID: 3929780
    [Abstract] [Full Text] [Related]

  • 2. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Macconi D, Morzenti G, Livio M, Morelli C, Cassina G, Remuzzi G.
    Lab Invest; 1985 Feb 30; 52(2):159-68. PubMed ID: 3155816
    [Abstract] [Full Text] [Related]

  • 3. Epinephrine potentiation of arachidonate-induced aggregation of cyclooxygenase-deficient platelets.
    Rao GH, White JG.
    Am J Hematol; 1981 Dec 30; 11(4):355-66. PubMed ID: 7331991
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ibuprofen protects platelet cyclooxygenase from irreversible inhibition by aspirin.
    Rao GH, Johnson GG, Reddy KR, White JG.
    Arteriosclerosis; 1983 Dec 30; 3(4):383-8. PubMed ID: 6411052
    [Abstract] [Full Text] [Related]

  • 6. Arachidonic acid-induced human platelet aggregation independent of cyclooxygenase and lipoxygenase.
    Maclouf J, Levy-Toledano S, Savariau E, Hardisty R, Caen JP.
    Prostaglandins; 1984 Sep 30; 28(3):383-98. PubMed ID: 6440214
    [Abstract] [Full Text] [Related]

  • 7. Iron chelators inhibit human platelet aggregation, thromboxane A2 synthesis and lipoxygenase activity.
    Barradas MA, Jeremy JY, Kontoghiorghes GJ, Mikhailidis DP, Hoffbrand AV, Dandona P.
    FEBS Lett; 1989 Mar 13; 245(1-2):105-9. PubMed ID: 2494068
    [Abstract] [Full Text] [Related]

  • 8. The role of arachidonate lipoxygenase and fatty acids during irreversible blood platelet aggregation in vitro.
    Dutilh CE, Haddeman E, Don JA, ten Hoor F.
    Prostaglandins Med; 1981 Feb 13; 6(2):111-26. PubMed ID: 6787628
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S, Krauze-Brzósko K, Manarini S, Evangelista V, Cerletti C.
    Eur J Pharmacol; 2004 Mar 19; 488(1-3):79-83. PubMed ID: 15044038
    [Abstract] [Full Text] [Related]

  • 11. In vitro effects of synthetic antioxidants and vitamin E on arachidonic acid metabolism and thromboxane formation in human platelets and on platelet aggregation.
    Agradi E, Petroni A, Socini A, Galli C.
    Prostaglandins; 1981 Aug 19; 22(2):255-66. PubMed ID: 6794104
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of platelet aggregation and reduced formation of thromboxane and lipoxygenase products in platelets by oil of cloves.
    Srivastava KC, Justesen U.
    Prostaglandins Leukot Med; 1987 Sep 19; 29(1):11-8. PubMed ID: 3118394
    [Abstract] [Full Text] [Related]

  • 13. Platelet lipoxygenase-dependent oxygen burst. Evidence for differential activation of lipoxygenase in intact and disrupted human platelets.
    Schafer AI, Turner NA, Handin RI.
    Biochim Biophys Acta; 1982 Sep 14; 712(3):535-41. PubMed ID: 6812645
    [Abstract] [Full Text] [Related]

  • 14. Comparative pharmacology of cyclooxygenase inhibitors on platelet function.
    Rao GH, White JG.
    Prostaglandins Leukot Med; 1985 Apr 14; 18(1):119-31. PubMed ID: 3159025
    [Abstract] [Full Text] [Related]

  • 15. Measurement of arachidonic acid liberation in thrombin-stimulated human platelets. Use of agents that inhibit both the cyclooxygenase and lipoxygenase enzymes.
    Smith JB, Dangelmaier C, Mauco G.
    Biochim Biophys Acta; 1985 Jul 09; 835(2):344-51. PubMed ID: 3924113
    [Abstract] [Full Text] [Related]

  • 16. Optimization of an assay for studying the effects of agents on cyclooxygenase and lipoxygenase metabolism of arachidonic acid in washed human platelets.
    Dragan YP, Ellis EF.
    Prostaglandins Leukot Essent Fatty Acids; 1990 Feb 09; 39(2):105-9. PubMed ID: 2111551
    [Abstract] [Full Text] [Related]

  • 17. Platelet hypersensitivity induced by 1-chloro-2, 4-dinitrobenzene, hydroperoxides and inhibition of lipoxygenase.
    Hill TD, White JG, Rao GH.
    Thromb Res; 1989 Mar 01; 53(5):447-55. PubMed ID: 2499941
    [Abstract] [Full Text] [Related]

  • 18. Salicylate fails to prevent the inhibitory effect of 5,8,11,14-eicosatetraynoic acid on human platelet cyclo-oxygenase and lipoxygenase activities.
    Cerletti C, Livio M, Doni MG, De Gaetano G.
    Biochim Biophys Acta; 1983 Aug 23; 759(1-2):125-7. PubMed ID: 6411131
    [Abstract] [Full Text] [Related]

  • 19. Influence of propranolol, pindolol, practolol and talinolol on arachidonic acid (AA)- and U-46619-induced aggregation and on AA-induced thromboxane A2 formation in platelets.
    Heinroth I, Block HU, Pönicke K, Förster W.
    Prostaglandins Leukot Med; 1983 Oct 23; 12(2):189-206. PubMed ID: 6139824
    [Abstract] [Full Text] [Related]

  • 20. Effect of docosahexaenoic acid (DHA) on arachidonic acid metabolism and platelet function.
    Rao GH, Radha E, White JG.
    Biochem Biophys Res Commun; 1983 Dec 16; 117(2):549-55. PubMed ID: 6229254
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.